Certain systems for estimation of toxicity to skin are discussed, in which fuller consideration of variables led to improved study design and better prediction of human hazard. Three areas are considered: skin irritation; dermal carcinogenesis; prediction of carcinogenic potential (in vitro). (1) Variation in the guidelines of various U.S. and foreign agencies for evaluation of skin irritation and corrosiveness of chemicals was addressed by use of multiple-site patching in the rabbit. Data obtained from this "composite assay," as well as from other published studies, indicated that no single set of guidelines was adequate for proper human hazard assessment. (2) Practical questions are raised about latency time and incidence of skin tumors from limited exposure to chemical carcinogens. In benzo[a]pyrene (BaP) carcinogenesis in mice, the duration of treatment is a key factor in tumor onset and frequency, with a "saturation level" resulting from interplay of duration and dose level. Age at inception of treatment can also be a factor in susceptibility to BaP-induced skin cancer, depending on conditions of exposure.
INTRODUCTION
IGNIFICANT BENEFITS CAN BE DERIVED from better evaluation of the variables in toxicology testing systems.
S This point can be demonstrated in three different systems used in the assessment of toxicity of materials to skin: (1) Dermal imtation studies. in vivo: (2) dermal carcinogenesis studies. in vivo: and ( 3 ) mutagenicity studies to predict dermal carcinogenicity potential, in vitro.
In each of these three areas, the factors believed to be of most significance are identified, and it is shown how they can affect the interpretation of data. The "husbandry variables" in animal testing: adequacy of nutrition, housing. and atmospheric controls, or whether animals were housed singly or in groups. have not been touched upon.
Environmental Health and Safety Department. Mobil Oil Corporation. Princeton. New Jersey.
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EXPERIMENTAL
Deriiial irritation evaluation: Acute studies
There has been strong interest in assessment of skin irritation potential of new materials. because dermatitis has been viewed as a widespread occupational problem.'" Assays for dermal imtation potential have normally been performed in the rabbit. using some variation of the Draize test."' This procedure employs 24-h application under occlusive dressing on both intact and abraded skin sites. which is a worst-case simulation of anticipated human exposure. A contact time of 24 h is probably excessive for any normal situation. particularly since rabbit skin is more sensitive to irritation than human skin. However, it provides an opportunity for discrimination among products that are only mildly irritating. and may better suggest which materials could be cumulatively irritating. The Draize assay is the one specified in the Federal Hazardous Substances Act (FHSA). administered by the Consumer Product Safety Commission (CPSC).
Perhaps recognizing the inappropriateness of the 24-h contact time, the Department of Transportation (DOT) opted for a 4-h contact time for assessment of potential corrosiveness. Other agencies in the U.S. and abroad subsequently developed their own modifications of the assay procedure, to which was added an additional condition (no occlusion) in Mobil's Toxicology Laboratory. The various guidelines are summarized in Table 1 .
Attempts to comply with rules of all of these agencies became both expensive and wasteful of animals. To respond constructively to this frustrating situation, a "composite assay" for skin imtation was developed, in which all of the necessary variables were included by multiple-site patching of the individual rabbits, with the six sites being evaluated by appropriate regulatory g~idelines.'~' This method assumes that any material tested has a low dermal toxicity (i.e.. LD, 1 g/kg body weight). and that there are no site-to-site interactions. (This latter variable has not been examined in depth. but in practice has seemed not to be a significant factor.) A considerable bank of data developed by use of the composite assay will be included in the following discussion.
Abrasion of test site
In evaluating the influence of site abrasion on imtation, McCreesh and Steinberg'" demonstrated that such abrasion of rabbit skin resulted in increased imtation for 10 of 24 household materials or industrial chemicals. In contrast. no effect of abrasion on the degree of imtation was found in any study using the composite assay mentioned above for evaluation of 80 petroleum-related chemical^.'^' In the latter studies, the materials tested were generally immiscible in water. which may explain, in part, the difference in results between the two groups. Water-soluble agents (particularly if charged) tend not to penetrate intact stratum corneum. Lipid-soluble chemicals not only penetrate more easily through the stratum comeum. but also may enjoy facilitated entry via the pilosebaceous Therefore. the effect of abrasion in breaking the skin barrier should be seen to a much greater extent with water-soluble chemicals than with lipid solubles. 
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VARIABLES IN EVALUATION OF TOXICITY TO SKIN
Occlusion of test site
Steinberg and associate^'^' found, contrary to their expectation, that occlusion of the test site did not enhance skin imtation in rabbits by a spectrum of organic compounds: aldehyde, acid, amide, cationic. sulfonamide, pyridinium. Gilman et al.,('") studied the effects of occlusion or semiocclusion. for various contact times. on imtation potential of powder anionic detergent. In contrast to Steinberg and asso~iates,(~'they found that after 24-h contact with skin. higher imtation scores were obtained consistently at the fully occluded sites, with dry powder, paste, or aqueous suspension. The authors stressed the inappropriateness of 24-h contact time and complete site occlusion in making estimates of potential consumer hazard.
For 78 petroleum-related materials tested by the composite assay. Cruzan and co-workers'3' found an irregular pattern in imtation scores for occluded versus uncovered sites. (The Draize scoring system was used, with a range of 0-8 for the least to the most imtating.) For 59 materials, impermeable occlusion of the site had no significant effect on development of imtation (i.e.. the difference in scores between occluded and nonoccluded sites was S0.5 units); for 13 there was an increase, and for 6, a decrease.
Among the materials that showed an increase in irritation scores when the site was occluded, the effect was extraordinary for those having a mean boiling range less than 500°F (260°C). the so-called "middle distillates" ( Table 2 ). For the materials shown, particularly light mineral oil and kerosene. the scores observed with occlusion would have mandated strict controls to avoid dermal exposure of workers. Without occlusion, these same materials would be viewed as inocuous or nearly so. Other substances in this category showed the same type of behavior, but to a lesser degree. The data indicate that for this class of materials, spillage on outside clothing could be virtually ignored. while trapping within shoes or other relatively impermeable clothing could be a cause for real concern, and should be so specified on material safety data sheets.
Contact time with test site
In the mid-1970s there was some regulatory concern about the 24-h contact time specified in the FHSA. When tested this way, household detergents formulated with alkaline proteinases would require labeling as being corrosive, while with more realistic contact times. these products were quite mild. Significant differences in irritation potential were seen also when powder anionic detergents were tested with contact times of 4 or 24 h."" While an agency proposal to modify the conditions for initation evaluation under FHSA died on the vine of government bureaucracy, the more realistic contact time of 4 h was subsequently adopted by the DOT and other agencies (Table 1) .
In studies using the composite assay.'" imtation tended to be greater the longer the (occluded) test material was in contact with the skin (24 vs. 4 hours). as might be expected. However, for a substantial number of tests (29 of 88). the Primary Imtation Index for a4-h contact time (PII,) was about the same as for a 24-h exposure (PI12J. The ratioof primary initation indices (PI124/PII,) ranged from 0.05 to 1.60. making it impossible to predict what a 24-h reading would be from knowledge of a 4-h reading. or vice versa. 
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Amount applied at test site
All of the agencies cited in Table 1 have used the same volume or mass (0.5 ml or 500 mg) for imtation testing. In a sense, this variable is balanced if the test results are interpreted by comparison with data obtained similarly for materials having a known history of human exposure and response.
Toxicity
Toxicity by the dermal route is usually not a problem in skin irritation studies, but may be a significant variable with certain agents; for instance, pesticides which can contain potent neurotoxins. For such materials the standard test procedures may be inapplicable, because the amount administered is lethal to the test animal. This is particularly true for the composite assay. in which the total dose applied on the six sites approximates 1 g/kg of body weight.
The primary inference from the above data is that, in assessment of new materials, the variable effects of abrasion, contact time, and occlusion need to be included to provide a sound basis for human hazard evaluation. There seems to be no way to predict, a priori, what the effect of any of these variables might be on skin imtation, and all three provide information which could profitably be included on material safety data sheets.
DERMAL CARCINOGENESIS EVALUATION
It has been proposed that the high frequency of cancer in the elderly results from a breakdown in the body's immunosurveillance system." ' Alternative explanations. such as impaired efficiency or fidelity of DNA repair, or decreased detoxification capability, have also been advanced. Assuming the truth of any of these premises, chemical carcinogens would be more potent in aged animals than in the young, and such a situation might be exploitable in terms of shorter, more efficient bioassays. This should apply to cancer of the skin as well as internal organs, and could possibly open the door to a better understanding of the processes leading to the development of cancer, and of how to combat them. This premise certainly deserves further inquiry, but as a practical matter, most carcinogenesis studies have been started in young animals both to maximize the period of dosing and to allow sufficient time for tumor expression.
Perhaps more important than simply defining the age-related susceptibility to carcinogens, is knowing the effects of other factors directly related to the potential hazard of carcinogens in the work place. One might ask: What are the consequences of occupational exposure of limited duration to carcinogenic chemicals? How long is "too long"? What is the more critical factor, (a) the level of exposure, or (b) the cumulative dose? The current discussion will be limited to consideration of only a few of the numerous studies performed to address these questions.
Duration of treatment
In bioassays for carcinogenic potential, continuous dosing for the lifetime of the animals has been the norm. A prominent exception has been the "megamouse" or ED,, study on CK induction of systemic carcinogenesis by oral dosing of 2-acetylaminofluorene (2-AAF). This study, conducted by the National Center for Toxicological Research to investigate the questions of latency and reversibility of tumor induction, included both serial sacrifice and discontinuance of treatment. The influence of duration (and dose level) on the induction of liver and bladder neoplasms in this study was interpreted by Farmer'"' and Littlefield."3' and their associates, who observed that their data did not support a "no threshold concept," and that, without really prolonged observation after exposure to a chemical, the carcinogenic potential might be grossly underestimated. In this ED, , , study, it was possible to treat duration as a single variable, and divorce it from the total (cumulative) dose administered. However, the shortest period of treatment was 9 months; using a life span ratio of 30 mouse-months to 70 man-years. this would be the equivalent of 20 man-years of exposure. This period of treatment is not short enough to provide a full answer to the question of "how long is too long?".
Dose level
In the performance of systemic carcinogenesis assays. three levels of the test material have usually been evaluated, with the highest level being the maximum tolerated dose (MTD)."" As many as seven dose levels of VARIABLES IN EVALUATION OF TOXICITY TO SKIN 2 A A F were used in the ED,, study. In contrast, a single high dose is most often used in dermal carcinogenesis screening assays. with the only criterion being whether the mice can survive repeated exposure to the agent at the level chosen.
Age at inception of treatment As mentioned above, carcinogenesis studies routinely are started early in the life of the animals in order to provide adequate time for extended exposure to the chemical and delayed expression of tumorigenicity . The ED,,, study was no exception in this regard, and could only conclude that age had no effect on the uniformity of response to the 2-AAF."" In the following discussion, which focuses on evaluation of variables in addition to age at inception of treatment. it will be shown how variations in the design of carcinogenesis studies can result in very different interpretations of the data with respect to potential human hazard.
Pet0 and his associate^"^' evaluated the effect of age at inception of dosing on dermal susceptibility to benzo[a]pyrene (BaP) carcinogenesis. Female Swiss mice were "skin painted' at a single dose level (40 pglweek) of BaP. starting at different ages (10,25,40. or 55 weeks of age). Tumor incidence was expressed as a function of the time required to produce malignancies after this continuous dosing with BaP. Their conclusion was that "the skin cancer incidence rates depend only on duration of carcinogenic insult. and given this duration. not at all on the age of the animals when regular exposure to the insult began." In this context. "duration of carcinogenic insult" seemed more properly to refer to the cumulative dose administered than to the single variable of time of treatment.
As stated, however, their conclusions are firmly supported by the data in Table 3 . in which tumor incidence is adjusted for time-to-tumor by lifetable.'16.17' Reading vertically. one can note the definite relation between duration of treatment and the percentage of mice with malignancies. Reading horizontally. it can be seen that this frequency is independent of the age at inception of treatment under these testing conditions, that is. when mice are dosed continually at a level of 40 Fgiweek (equivalent to about 1 mglkgiweek for a 40 g mouse). The conclusions may not be the same under other testing conditions, such as those to be discussed next.
Several of the variables cited above, including age at inception of treatment, were more recently investigated by Cruzan and co-workers'18' in a series of dermal carcinogenesis studies with BaP. The study design is outlined in Figure 1 . In the first part of the study, young C3H male mice were dosed with 0.01% or 0.05% BaP in an acetone vehicle for the period of time shown along the horizontal axis: treatment was then discontinued and the animals observed until they died or were sacrificed. The italicized numbers were the projected durations of treatment or observation; the conventional numbers are the actual duration. A modification of the original schedule was required because the tumor incidence was higher than anticipated at the longer periods of exposure. In the second part of the study, dosing of nai've mice was started at the 52nd week of the study. for the periods indicated. Regarding the dose levels: the 0.01 5 % solution is equivalent to 10 Fgiweek, the 0.05% solution to 50 pgiweek. spanning the level of 40
Fgiweek used by Peto. et al. '15' The results of this study are summarized in a schematic (Fig. 2 ) prepared from tumor incidence data provided by Cruzan. On the vertical axis, are shown the BaP concentration (0.01% or 0.05%) and duration of treatment (26 weeks, etc.). On the honxontal axis, are plotted the times of appearance of the lst, 10th. and 20th tumor. The number of tumor-bearing mice was recorded only every 4 weeks, so that the actual number of mice with tumors at each time point may have been greater than indicated. As an example, for the group treated at 0.01% BaP for 26 weeks. there were 23 (not 20) animals with tumors at the 68th week. 
VARIABLES IN EVALUATION O F TOXICITY TO SKIN
As shown in Figure 2 . in the mice treated with 0.01% BaP for 26 weeks, the first tumor appeared at 40 weeks, the tenth by 52 weeks, and the 20th by 68 weeks, When this treatment was continued for some period greater than 26 weeks, there was a shift to the left in the time of appearance of the first tumor, and a compression of the time frame for appearance of subsequent tumors. A similar pattern was noted with 0.05% BaP treatment, but the leftward shift was greater, and the degree of compression much greater. With 6 weeks of treatment at 0.05%. other tumors were seen in addition to the two that appeared at week 36 of the study; the 10th to 12th tumors appeared between weeks 96 and 100 of the study.
Inspection of Figure 2 reveals that, at a given dose level, there was a minimum time for appearance of the first tumor. At0.01% (10 @week) of BaP. the minimum time to tumor was 32 weeks, and at 0.05% (50 )*g/week). 20 weeks. Anyone familiar with dermal carcinogenesis testing of polycyclic aromatic compounds (PAC) could have anticipated that exposure to increasing concentrations of the BaP would result in a shorter latency period and a steeper slope of response, as well as a higher incidence of malignant tumors. Not expected, however, was the "saturation effect" with respect to these parameters, as a function of time of exposure at a given dose level. As the duration of treatment with BaP was lengthened, the initial latency period (time to first tumor). as well as the average time to tumor, decreased to a point where increasing duration of treatment further produced no heightening of the response. Hence, a saturation point was reached at that specific dose level. The time of treatment required to reach the saturation point was shorter at the higher dose level.
There was greater uniformity of response among the test animals to the tumorigenic action of BaP as the dose level of BaP and duration of exposure were increased; this can be inferred from the degree of compression of the response profiles shown in Figure 2 . At the 0.05% treatment level, a near-homogeneity in response was obtained at the saturation point.
It was commented earlier that when possible, a distinction should be made between duration of exposure and the total (cumulative) dose applied to the animals; this can not be done. of course, when dosing is done continuously. In these studies"*' in which treatment with BaP was curtailed after specific periods. such a distinction could be made. When response was evaluated at comparable total dose ( Table 4 ). the tumor incidence was much lower when the duration of exposure was shorter. This was most marked for the briefer periods of exposure (6 vs. 26 weeks). but was also evident at the longer exposure times (13 vs. 52 weeks).
In this same series of studies,"*' an additional segment focused on the relative susceptibility of "aged" vs. "young" male C3H mice to chemically induced tumorigenesis. Application of 0.01% BaP in acetone on the aged mice was begun on the 52nd week of the study, when the mice were about 60 weeks of age.
Starting at this point in the study, the number of mice who were still alive at several arbitrarily chosen time intervals is shown ( Table 5 ). While survival at the 52nd week of the study was nearly equivalent in all groups (range 92-98%), survival of the BaP-treated mice was 24% higher than the acetone-treated controls by the 84th week, and about 200% greater at 104 weeks; in other words, the number of BaP-treated mice alive at the end of the study was three times that of the acetone-treated controls (and twice that of the untreated controls). A simple hypothesis for the markedly increased longevity of the BaP-treated mice would be that exposure to this chemical stimulated metabolic inactivation of potentially debilitating chemicals, perhaps the free radicals to which aging (and death) have often been aGroups of 50 mice were 8 weeks of age at initiation of study.
We now turn to tumor incidence in the aged mice, compared with that in the young mice treated for the same period of time and at the same level of BaP (Table 6 ). After treatment with 0.01% BaP for 26 weeks or for 52 weeks, tumor incidence was remarkably lower in the mice whose treatment was begun at about midlife (60 weeks of age), compared with mice whose treatment was initiated just after weaning (8 weeks of age). Other investigators may have missed this age-related phenomenon because their dose levels were excessive and/or the treatment of their animals was either continuous or not of sufficiently limited duration.
In addition, then, to the observation that there was a saturation effect with respect to carcinogenic potency. involving an interplay of both dose level and treatment duration, there was the apparently unrelated finding of a markedlv increased resistance to tumorigenesis in aged mice. The implications of the above findings for control of work place exposure to known carcinogenic materials seem obvious. One other aspect, whether there is an oncogenesis threshold based on duration of exposure, was not answered in this study. Similar to the findings of Littlefield et a1.,(I3' in the oral induction of bladder tumors by 2-AAF, both shortening the period of dermal exposure to BaP and lowering the dose level decreased the probability of skin tumors. Therefore. a practical threshold may exist for short-term exposure at a low level.
IN VITRO MUTAGENICITY STUDIES TO PREDICT DERMAL CARCINOGENICITY POTENTIAL
Materials can be screened for potential to cause skin cancer in considerably less sophisticated studies than those described above. However, the extended duration of these studies, which are usually conducted for 18 to 24 months, makes them useless for day to day decisions that have to be made in the petroleum industry, for instance, whether a new crude stock is, or is not, acceptable for formulation in currently produced products.
Mutagenicity tests have proved to be effective screens for potential carcinogenesis in consumer product, pharmaceutical, and chemical industries, but have not served the oil industry in the same way. The conventional mutagenicity tests rely on water solubility of the test material to confer bioavailability, and are rather insensitive to the water-immiscible materials most usually encountered in the oil industry. (2'-23' In a study performed for the American Petroleum I n s t i t~t e , '~~"~' 13 oils previously evaluated for carcinogenic potential by dermal bioassay in the mouse were tested for mutagenic activity by the conventional Ames test (Salmonella Revertant Mutagenicity Assay). Of these oils. only one gave a positive mutagenic response. This lack of mutagenic activity was attributed primarily to inadequate interaction of the oils with the test system bacteria.'"' Nevertheless. such a bacterial assay system would be of great value for rapidly screening complex mixtures. such as petroleum streams. for the presence of mutagens. To investigate the utility ofthe Ames test for such evaluations. three prime variables would have to be dealth with: ( 1 1 bioavailability: (2) conversion of promutagens to the active form; and finally, ( 3 ) correlation of mutagenicity data with results of the mouse bioassay for dermal carcinogenesis. Another desired step would be to identify the active materials on which such predictions would be based.
Bioavailabilih
A number of investigators'"." '' have noted that when carcinogenic refinery streams are solvent extracted. the carcinogenic activity disappears. This applies most particularly to streams with a mean boiling range above 500°F (260°C). In their modification of the standard Ames test, two steps were taken by Blackburn and co-workers''X' to enhance interaction of any mutagenic agent(s) with the bacterial cells. Test samples were first dissolved in cyclohexane, a procedure which makes the modification applicable even to highly viscous or solid samples. The cyclohexane solution was then extracted (once) with dimethylsulfoxide (DMSO) to "isolate" the fraction that may contain mutagens.
Bioactivation
Source of S-9. Many potential mutagens and carcinogens require metabolic conversion before they are active.
Because bacterial systems lack the complete biotransformation systems present in mammals, Ames and his associate^"^' enhanced the effectiveness of their Salmonella rykirnurium assay procedure by including in the medium a rat liver extract ("S-9") rich in metabolizing enzymes. In their modification, Blackburn and co-workers"*' changed the source of this metabolizing mixture from the rat to the hamster (Table 7) . on the basis of published reports that hamster S-9 was superior for activation of complex mixtures containing polycyclic aromatic compounds (PACS).'~") The hamster S-9 apparently allows testing at higher doses of the oils. imparting greater sensitivity for detecting the presence of any mutagenic components therein.
Concentration of S-9
Carver and M a~G r e g o r '~! ' found that a 10-fold increase over the standard Ames test concentration of S-9 was optimal for assay of mutagenic activity of a distillation fraction. Increasing the S-9 level may serve to overcome the action of the PACs in inhibiting their own oxidation.'"' which is the important activation reaction for this class of compound. In the Ames test m o d i f i c . a t i o n~. "~~~~~~~' the concentration of both the S-9 and cofactor NADP were increased ( Table 7) .
Bacterial strain
fiphirnuriurn strains used in the standard assay (Table 7 ).
Further efficiency was achieved"8-3.'4' by using only strain TA98, the most PAC-sensitive of the five S. The increased sensitivity of the Ames test as modified for petroleum-related products would have little value if the correlation between mutagenicity and dermal carcinogenicity did not hold. A high level of correlation (r = 0.92) was, in fact, found between mutagenicity data (modified Ames test) and mouse bioassay data for 18 samples with mean boiling points >500"F ( Table 8 ). There was significant variability in the ratio of the mutagenicity index (MI) to the carcinogenicity index (CI), perhaps due to inefficient extraction of mutagenic components, or to expression of mutagenic activity with no counterpart in dermal carcinogenic activity. This variability does limit the applicability of the modified assay to predict, within narrow limits, the potency of a given sample for elicitation of dermal cancer. However, the high overall correlation between mutagenicity and carcinogenicity does allow the use of cut-off scores to judge, with a high level of probability, whether a sample has an acceptably low carcinogenic potential.'28' Further, such a prediction can be made within a very short period of time (about 1 week), thereby satisfying the needs of those in the petroleum industry who do not have the luxury of several years' time in making such decisions.
In an analytical follow-up to the cited mutagenicity studies, Roy and co-worker~'~~' characterized 39 refinery stream samples on which mouse dermal carcinogenesis studies had been performed by various oil companies. Following DMSO extraction of cyclohexane dilutions of the oil samples, the PACs were isolated and quantified, and modified Ames tests for mutagenicity performed on the same samples. While there was variation between the mutagenicity and carcinogenicity indices in the fashion already discussed, the concentration of the 3-7-ring PACs showed a remarkably consistent relation with mutagenic activity of the samples. This indicated clearly that this class of compound was responsible for the observed mutagenic activity. For example, for the 24 samples for which neither parameter (MI or PAC content) had a zero, the mean value of the ratios was 1.02, with a narrow range of 0.73 to 1.40.
SUMMARY
Three areas of dermal toxicity evaluation (skin irritation, dermal carcinogenesis, and in vitro prediction of dermal carcinogenesis) have been discussed, in which re-evaluation of the variables led to more efficient and more predictive ways to evaluate potential human hazard. While much of this relied on careful search of the published literature, much more depended on the willingness of investigators to re-examine the validity of past assumptions.
